Abstract:The choice of appropriate adeno-associated virus serotypes for gene therapy to the human lung can differ depending on the animal model and model system in which such serotypes are evaluated. In the present study, we sought to compare the efficiency of rAAV2/1, rAAV2/2, and rAAV2/5 vector transduction in polarized human airway epithelia. Since similar vector purity is paramount to such a comparison, we developed a uniform procedure for purification of these serotype vectors using an adenovirus-free packaging system and HPLC. Results from these experiments demonstrated that apical transduction of human polarized airway epithelia with rAAV2/1 was 100-fold more efficient than rAAV2/2 and rAAV2/5. Additionally, the profile of apical transduction in human airway epithelia (rAAV2/1>>rAAV2/2=rAAV2/5) was significantly different than that seen following nasal administration of these vectors to mouse lung (rAAV2/5>rAAV2/1>>rAAV2/2), emphasizing differences in transduction of these serotypes between these two species. In stark contrast to rAAV2/2 and rAAV2/5 vectors, which demonstrated much greater transduction efficiencies from the basolateral membranes, rAAV2/1 transduced both apical and basolateral membrane of human airway epithelia with similar efficiency. Such serotype-specific difference in apical and basolateral transduction mirrored differences in internalization of vector genomes at short time points post-infection for a given serotype. However, the overall level of transduction across serotypes did not correlate with vector internalization. These results suggested that enhanced receptor-mediated endocytosis was not likely responsible for the greater rAAV2/1 transduction of human airway epithelia. With the hypothesis that differences in post-entry barriers influenced the efficiency of apical transduction with these three serotypes in the human airway, we tested the effectiveness of proteasome inhibitors (LLnL and doxorubicin, known to augment intracellular processing of rAAV2 and rAAV5 to the nucleus) to augment transduction with these three serotypes. Augmentation of rAAV2/1 apical transduction of human polarized airway epithelia was 10-fold lower than that for rAAV2/2 and rAAV2/5. Cellular fractionation assays demonstrated that proteasome inhibitors significantly increased virion nuclear uptake for rAAV2/2 and rAAV2/5, but not for rAAV2/1. Cumulatively, these findings suggest that the ubiquitin/proteasome pathway is less of a barrier for rAAV2/1 as compared to the other AAV serotypes. They also demonstrate that AAV1 serotype transduction biology is quite different from AAV2 and AAV5 in human airway epithelia and is potentially a more efficient vector for gene therapy to the airway.

Comparative Analysis of AAV Serotypes for Transduction of Olfactory Sensory Neurons

Comparative analysis of six adeno-associated viral vector serotypes in mouse inferior colliculus and cerebellum

Identification of Broadly Applicable Adeno-Associated Virus Vectors by Systematic Comparison of Commonly Used Capsid Variants In Vitro

Direct dorsal root ganglia (DRG) injection in mice for analysis of adeno-associated viral (AAV) gene transfer to peripheral somatosensory neurons

Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection

AAV9-Retro mediates efficient transduction with axon terminal absorption and blood–brain barrier transportation

Distributional Comparison of Different AAV Vectors after Unilateral Cochlear Administration

Adeno-associated Virus Vectors Efficiently Transduce Mouse and Rabbit Sensory Neurons Coinfected with Herpes Simplex Virus 1 following Peripheral Inoculation

Transduction of Adeno-Associated Virus Vectors Targeting Hair Cells and Supporting Cells in the Neonatal Mouse Cochlea

In vivo dynamics of AAV-mediated gene delivery to sensory neurons of the trigeminal ganglia

Identification of Adeno-Associated Viral Vectors That Target Neonatal and Adult Mammalian Inner Ear Cell Subtypes.

Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain

A comprehensive study of a 29-capsid AAV library in a non-human primate central nervous system

Unique Biologic Properties of Recombinant Aav1 Transduction in Polarized Human Airway Epithelia

10. Adeno-Associated Virus Type-1 Vectors Transduce Human Polarized Airway Epithelia Without Polarity Preference

Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants

Targeted Gene Delivery into the Mammalian Inner Ear Using Synthetic Serotypes of Adeno-Associated Virus Vectors

A Comprehensive Atlas of AAV Tropism in the Mouse

Common AAV gene therapy vectors show indiscriminate transduction of living human brain cell types

Natural Adeno-Associated Virus Serotypes and Engineered Adeno-Associated Virus Capsid Variants: Tropism Differences and Mechanistic Insights

Transduction Efficiencies of Novel AAV Vectors in Mouse Airway Epithelium in Vivo and Human Ciliated Airway Epithelium in Vitro